3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Weight Loss
1
Pancreatic Neoplasms
1
Hematologic Neoplasms
1
Disease
1
Cachexia
1
Adenocarcinoma
1
Interventions
Fluorouracil
11
Gemcitabine
8
pembrolizumab
7
Leucovorin
7
Irinotecan
7
Paclitaxel
6
Oxaliplatin
5
Carboplatin
5
130-nm albumin-bound paclitaxel
5
Nivolumab
4
Cisplatin
4
Albumin-Bound Paclitaxel
4
Taxes
3
Ramucirumab
3
Radiosurgery
3
Pemetrexed
3
Docetaxel
3
Capecitabine
3
Bevacizumab
3
vandetanib
2
spartalizumab
2
selinexor
2
osimertinib
2
folfirinox
2
Radiation
2
Cyclophosphamide
2
zolbetuximab
1
trastuzumab deruxtecan
1
trametinib
1
tofacitinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Adenocarcinoma
×
bermekimab
×
Clear all
NCT03207724
2020-12-30
OnFX
Cedars-Sinai Medical Center
Phase 1
Completed
16 enrolled